Latest News and Events
Filter by
Selections
May 14, 2018
Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
Read MoreMay 11, 2018
Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline
Read MoreMay 1, 2018
Arrowhead Pharmaceuticals to Present Preclinical Data on Emerging Pipeline of RNAi Therapeutics
Read MoreApril 11, 2018
Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™
Read MoreMarch 28, 2018
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
Read MoreMarch 27, 2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Read MoreMarch 20, 2018